Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration

Negm, OH, MacKenzie, B, Hamed, MR et al. (9 more authors) (2017) Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. Clinical & Experimental Immunology, 188 (3). pp. 437-443. ISSN 0009-9104

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 British Society for Immunology. This is the peer reviewed version of the following article: Negm, OH, MacKenzie, B, Hamed, MR et al. (9 more authors) (2017) Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration. Clinical & Experimental Immunology, 188 (3). pp. 437-443. ISSN 0009-9104, which has been published in final form at https://doi.org/10.1111/cei.12946. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Keywords: antibodies; Clostridium difficile; intravenous immunoglobulin
Dates:
  • Published: June 2017
  • Accepted: 14 February 2017
  • Published (online): 18 February 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 10 May 2017 13:03
Last Modified: 18 Feb 2018 01:38
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1111/cei.12946

Share / Export

Statistics